Albireo Pharma Inc (NASDAQ:ALBO)

33.38
Delayed Data
As of Sep 30
 +0.74 / +2.27%
Today’s Change
11.26
Today|||52-Week Range
49.00
+31.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.001.0K12.7M
 
 
 
Depreciation And Amortization197.0K81.0K34.0K47.0K
 
 
 
 
 
 
Operating ExpensesGross Income-197.0K-81.0K----
 
 
 
General Expenses19.6M10.6M28.2M49.7M
 
 
 
 
 
Other Operating Expenses0.000.00841.0K837.0K
 
 
 
Research And Development13.4M3.7M13.0M31.7M
 
 
 
 
 
Total Operating Expenses19.8M10.7M29.1M50.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.8M-10.7M-29.1M-37.9M
 
 
 
 
 
Extraordinary Credit1.0M4.0K0.000.00
 
 
 
Extraordinary Charge0.00-3.3M0.000.00
 
 
Interest Expense On Debt0.000.00--4.8M
 
 
Other Expenses50.0K264.0K4.8M-3.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.7M-13.7M-24.2M-46.1M
 
 
 
 
 
Income Taxes-29.0K-52.0K-212.0K-20.0K
 
 
 
 
 
Net Income-18.7M-13.8M-24.4M-46.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.4M2.1M7.8M11.7M
 
 
 
 
 
Shares To Calculate EPS Diluted1.4M2.1M7.8M11.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$13.80-$6.45-$3.12-$3.94
 
 
 
 
 
EPS Diluted-$13.80-$6.45-$3.12-$3.94